T1	Participants 985 997	110 patients
T2	Participants 759 983	undertaken in 16 centres in four European countries. Patients aged 18-80 years were eligible for enrolment if they had stable VT, previous myocardial infarction, and reduced left-ventricular ejection fraction (LVEF; <or=50%)
T3	Participants 2657 2730	patients with stable VT, previous myocardial infarction, and reduced LVEF
